Clinical Trial Update: Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of exenatide in adults with type 2 diabetes mellitus and congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Type 2 Diabetes Mellitus, Congestive Heart Failure | Phase 4 | Status: COMPLETED